Inventor · disambiguated record
Frank Matthias Dautzenberg
Also filed as: DAUTZENBERG FRANK · DAUTZENBERG FRANK MATTHIAS
8 granted patents·1 pending application·42 citations·filing 1999–2020
83Inventor score
Files withHOFFMANN LA ROCHE4ANDRES-GIL JOSE IGNACIO2CID-NUNEZ JOSE MARIA1JANSSEN PHARMACEUTICALS INC1NOVALIQ GMBH1
Top patents by PatentIndex Score
9 records- 0191US7265125B2Neuropeptide Y antagonistsHOFFMANN LA ROCHE·Filed 2005·Granted Sep 4, 2007·18 cites·45 claims
- 0285US8158643B2Substituted diaza-spiro-pyridinone derivatives for use in MCH-1 mediated diseasesANDRES-GIL JOSE IGNACIO·Filed 2007·Granted Apr 17, 2012·11 cites·23 claims
- 0373US8841323B21, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptorsCID-NUNEZ JOSE MARIA·Filed 2007·Granted Sep 23, 2014·2 cites·7 claims
- 0471US9266834B21, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptorsJANSSEN PHARMACEUTICALS INC·Filed 2014·Granted Feb 23, 2016·2 cites·14 claims
- 0562US6657060B2Pyrimidine derivativesHOFFMANN LA ROCHE·Filed 2001·Granted Dec 2, 2003·1 cites·60 claims
- 0649US6900226B2Neuropeptide Y antagonistsHOFFMANN LA ROCHE·Filed 2001·Granted May 31, 2005·0 cites·76 claims
- 0749US6075034ASpiro[piperidine-4,1'-pyrrolo [3,4-C] pyrrole]derivativesHOFFMANN LA ROCHE·Filed 1999·Granted Jun 13, 2000·8 cites·53 claims
- 0841US8329704B2Substituted pyrazinone derivatives for use in MCH-1 mediated diseasesANDRES-GIL JOSE IGNACIO·Filed 2006·Granted Dec 11, 2012·0 cites·13 claims
- 0940US2022008397A1Pharmaceutical composition for the treatment of ocular neovascularisationNOVALIQ GMBH·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →